A phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in the intensification of cisplatin and cyclophosphamide chemotherapy for advanced ovarian cancer.

A pilot study was undertaken in eight patients to assess the feasibility of recombinant human granulocyte-macrophage colony-stimulating factor (rH GM-CSF) support to intensify standard chemotherapy for advanced ovarian cancer using a shortened 15 day treatment interval. Only four patients completed...

Descripción completa

Detalles Bibliográficos
Autores principales: Kehoe, S., Poole, C. J., Stanley, A., Earl, H. M., Blackledge, G. R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968837/
https://www.ncbi.nlm.nih.gov/pubmed/8123484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968837/
https://www.ncbi.nlm.nih.gov/pubmed/8123484

Ejemplares similares